The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Reinforcing Radiotherapy of Gallbladder Cancer with Aclarubicin and Neocarzinostatin
SHINICHI OKUYAMAHITOSHI MISHINAKENICHI FUNAKITOSHIHIKO MORI
著者情報
ジャーナル フリー

1990 年 161 巻 2 号 p. 155-156

詳細
抄録
OKUYAMA, S., MISHINA, H., FUNAKI, K. and MORI, T. Reinforcing Radiotherapy of Gallbladder Cancer with Aclarubicin and Neocarzinostatin. Tohoku J. Exp. Med., 1990, 161 (2), 155-156-Cancer of the gallbladder is radioresistant. When a 59-year-old woman was found to have an inoperable cancer of the gallbladder, she was subjected to radiotherapy combined with aclarubicin and neocarzinostatin. Therapeutic effectiveness was confirmed at autopsy as she later succumbed to uterine cervical cancer. Thus, the present radiochemotherapeutic regimen would probably provide a means of overcoming those radioresistant inoperable malignancies.
著者関連情報
© Tohoku University Medical Press
前の記事 次の記事
feedback
Top